# Treatment of Severe Infections With Mesenchymal Stem Cells

> **NCT02883803** · NA · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 66 (estimated)

## Conditions studied

- Septic Shock

## Interventions

- **BIOLOGICAL:** Injection of mesenchymal stem cells
- **BIOLOGICAL:** Injection of albumin alone

## Key facts

- **NCT ID:** NCT02883803
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12
- **Primary completion:** 2021-11
- **Final completion:** 2022-11
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2019-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02883803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02883803, "Treatment of Severe Infections With Mesenchymal Stem Cells". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02883803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*